Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects

Robert Busch*, Brian D. Hobbs, Jin Zhou, Peter J. Castaldi, Michael J. McGeachie, Megan E. Hardin, Iwona Hawrylkiewicz, Pawel Sliwinski, Jae-Joon Yim, Woo Jin Kim, Deog K. Kim, Alvar Agusti, Barry J. Make, James D. Crapo, Peter M. Calverley, Claudio F. Donner, David A. Lomas, Emiel F. Wouters, Jorgen Vestbo, Ruth Tal-SingerPer Bakke, Amund Gulsvik, Augusto A. Litonjua, David Sparrow, Peter D. Pare, Robert D. Levy, Stephen I. Rennard, Terri H. Beaty, John Hokanson, Edwin K. Silverman, Michael H. Cho, Natl Emphysema Treatment Trial Gen, Evaluation COPD Longitudinally Ide, Int COPD Genetics Network, COPDGene Investigator

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)35-46
Number of pages12
JournalAmerican Journal of Respiratory Cell and Molecular Biology
Volume57
Issue number1
DOIs
Publication statusPublished - Jul 2017

Keywords

  • chronic obstructive pulmonary disease
  • genetic epidemiology
  • genetic risk factors
  • alpha-1 antitrypsin
  • genetic risk score
  • GENOME-WIDE ASSOCIATION
  • AIR-FLOW OBSTRUCTION
  • LUNG-FUNCTION
  • COMPLEX DISEASE
  • COPD
  • EMPHYSEMA
  • SMOKING
  • RECLASSIFICATION
  • SUSCEPTIBILITY
  • EPIDEMIOLOGY

Cite this